Journal article icon

Journal article

Two new dopamine agonists that are long acting in vivo but short acting in vitro.

Abstract:
The effects of two new ergolines, pergolide and CH29-717, on prolactin secretion in vitro and in vivo were compared with those of bromocriptine. Both ergolines had in vitro potencies similar to that of bromocriptine, but had a shorter duration of action. However, in vivo both were longer acting than bromocriptine after a single dose of 100 micrograms, and effectively suppressed prolactin secretion for greater than 24 h. It would appear that the pharmacokinetics of these ergolines are different to those of bromocriptine, and this may have considerable therapeutic importance.
Publication status:
Published

Actions

Access Document

Publisher copy:
10.1111/j.1365-2265.1980.tb03428.x

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
RDM
Sub department:
OCDEM
Role:
Author


Journal:
Clinical endocrinology More from this journal
Volume:
13
Issue:
6
Pages:
595-599
Publication date:
1980-12-01
DOI:
EISSN:
1365-2265
ISSN:
0300-0664


Language:
English
Keywords:
Pubs id:
pubs:138769
UUID:
uuid:eae0742c-61b6-448c-ac16-93db32838192
Local pid:
pubs:138769
Source identifiers:
138769
Deposit date:
2012-12-19
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP